ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
6.47
-0.31 (-4.57%)
Dec 5, 2025, 4:00 PM EST - Market closed
ImageneBio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| Net Income | -43.25 | -36.57 | -21.15 |
| Depreciation & Amortization | 0.57 | 1.53 | 3.1 |
| Loss (Gain) From Sale of Assets | -0.01 | 1.27 | 0 |
| Loss (Gain) From Sale of Investments | -0.03 | - | -0.14 |
| Other Operating Activities | 0.34 | 13.97 | -0.94 |
| Change in Accounts Payable | -0.47 | -0.52 | 3.89 |
| Change in Unearned Revenue | -0.79 | 0.51 | -0.14 |
| Change in Other Net Operating Assets | -15.79 | -1.5 | -2.85 |
| Operating Cash Flow | -44.1 | -21.32 | -18.23 |
| Capital Expenditures | - | - | -0.31 |
| Sale of Property, Plant & Equipment | 0.1 | 0.97 | 0 |
| Investment in Securities | 0.77 | 10.15 | -10.15 |
| Investing Cash Flow | -4.35 | 11.12 | -10.45 |
| Short-Term Debt Issued | - | 7.5 | - |
| Total Debt Issued | 22.5 | 7.5 | - |
| Net Debt Issued (Repaid) | 22.5 | 7.5 | - |
| Issuance of Common Stock | 71.18 | - | 0.15 |
| Other Financing Activities | 48.7 | -0.59 | - |
| Financing Cash Flow | 142.37 | 6.91 | 0.15 |
| Foreign Exchange Rate Adjustments | 0.62 | 0.09 | -0.15 |
| Net Cash Flow | 94.55 | -3.2 | -28.69 |
| Free Cash Flow | -44.1 | -21.32 | -18.54 |
| Free Cash Flow Margin | -5512.63% | -609.11% | -232.83% |
| Free Cash Flow Per Share | -0.11 | -0.05 | -0.06 |
| Cash Income Tax Paid | 0.23 | 0.22 | 0.12 |
| Levered Free Cash Flow | - | -21.2 | - |
| Unlevered Free Cash Flow | - | -21.2 | - |
| Change in Working Capital | -17.05 | -1.52 | 0.9 |
Source: S&P Capital IQ. Standard template.
Financial Sources.